In current knowledge-based treatment planning for intensity-modulated radiation therapy (IMRT), 3-dimensional dosimetric goals are predicted to provide abundant and appropriate starting points for planning optimization, but considering there're uncertainties with those dose distribution predictions, how to tailor the objective function and constraints accordingly is quite a concern. Here, we represent a novel automatic treatment optimization method that is capable of making the most of dose distribution prediction meanwhile achieving its optimum as much as possible. On the foundation of an in-house organsat-risk (OARs) dose distribution prediction model, we reformulate a traditional fluence map optimization (FMO) model by a predicted dose distribution-based objective, an equivalent uniform dose sparing for OARs and hard dose constraints for planning target volume (PTV). Feasibility and performance of the method is evaluated with 10 gynecology (GYN) cancer IMRT cases by comparing the plan quality of the generated to the original clinical ones, in the term of dose-volume-histogram (DVH) curves, dose distribution and detailed dosimetric endpoints. Results show plan quality improvement by our proposed method, with comparable PTV dose coverage but further dose sparing for OARs. Among 6 investigated OAR dosimetric endpoints, 4 of them are observed with significant improvement (P<0.05), V 30 , V 45 of rectum is decreased by (8.42±7.88) %, (15.49±7.48) %, respectively and V 30 , V 45 of bladder is decreased by (14.47±5.08) %, (14.24±4.71) %, respectively. We have successfully developed a novel automatic optimization method which is able to make good use of 3D dose prediction and ensure the output plan quality for IMRT.
I. INTRODUCTION
Treatment planning in intensity-modulated radiation therapy (IMRT) [1] - [5] is a trial-and-error process, patientspecific dosimetric goals have to be iteratively tuned and then achieved according to planner's experience, which
The associate editor coordinating the review of this manuscript and approving it for publication was Ying Song . causes low efficiency and plan quality variations [6] - [11] . A geometry-dosimetry correlation model learnt from previous plans could help predict the individualized plan dosimetric goals and afford a well-performed start-point for the knowledge-based treatment planning (KBTP) [12] - [21] . For example, RapidPlan in commercial treatment planning system (TPS) Varian Eclipse referenced dose-volume-histogram (DVH) predictions and picked specific dosimetric endpoints to guide and generate the optimal plan. Strategy like this by uniting a dosimetry prediction and a prediction guided optimization, more specifically a traditional optimization method, but initializing the goals or constraints using the predicted values, is a common KBTP implementation framework and has already been proven to be able to afford a feasible plan and meanwhile spare large amount of time and efforts [15] - [16] .
Conventional predicted goals like DVHs or their endpoints are cumulative distributions summed over the spatial dose, whose usage as goals makes the optimization lose exquisite control on spatial dose and remains on an organ level, thereby leads to exacerbating patient outcomes [22] , [23] . Rather than these, 3-dimensional dose distribution prediction [24] , [25] for optimization was preferred. Besides, most of KBTP researches were focusing on developing more sophisticated dose prediction, the applications of those prediction on following prediction guided optimization were barely mentioned. But without a reasonable utilization, even the most sophisticated prediction may not be able to provide a proper or even feasible plan [18] . Mcintosh et al predicted 3D dose and applied dose mimicking method [25] to generate a plan no worse than the prediction, specifically by minimizing the DVH differences between current dose distribution and the predicted one. Hu et al oriented the dose grid towards the prediction [26] by directly using the predicted 3D dose distribution as optimization goal to minimize the voxel-tovoxel dose differences between optimized dose distribution and the prediction [26] . All those methods took prediction re-creation as the applying strategy for predicted dose in optimization, although deliverable plans could be produced, they may not be essentially optimal given that those optimizations were prediction-oriented, the prediction error is obviously inevitable yet inconclusive and might reflect in the final dose. Besides, the optimization stops once the dose distribution reaches prediction, the solution space of optimization is limited. As for a prediction guided planning, exploiting the advantages of prediction to the full while finding a supplementary way to address its limitation is important and rather necessary. The general equivalent uniform dose (gEUD) [27] was invented to describe the responses of tumor or organs on dose, it has decent derivability, convexity and allows greater universe of optimization solution, which could be a great solution to the limitation of predicted dose.
Here, we investigated a well-organized planning framework for prediction guided optimization based on an OAR 3D dose prediction model and gEUD dose sparing. In this work, we first use an artificial neural network (ANN) to predict the dose distributions for OARs [28] and utilize them as objective goal to quickly orient current dose distribution to the prediction as close as possible even if the prediction is tight, by employing hard constraints to ensure PTV dose coverage. After appropriate plan achieves, a gEUD objective is then integrated to obtain further OAR dose sparing and compensate for the plan variation if guided by loose prediction. This method is well of putting 3D dose prediction into great use and meanwhile ensuring optimized plan quality. Feasibility and performance of this method is evaluated with 10 GYN IMRT cases by comparing the generated plans with the original ones on plan quality, in terms of DVH, dose distribution, and dosimetric endpoints.
II. METHODS AND MATERIALS
We constructed this dose prediction oriented automatic plan optimization framework with two parts: (1) OAR 3D dose distribution prediction, implemented by an in-house geometrydosimetry correlation model, this model is initially trained via an ANN from a cohort of prior-treated quality accepted IMRT plans and then fed to the new coming test set.
(2) Predicted dose distribution and gEUD based planning optimization, with a purpose of letting OARs achieve their prediction results while pushing them to receive as minimum dose as possible. Dose distribution prediction is used as the dosimetric reference for OAR objective in a fluence map optimization (FMO) with constraints, to guide a plan no worse than the predicted. Then an equivalent uniform dose sparing is employed to provide a way to further reduce OAR doses. For case study, 10 GYN IMRT plans are selected and evaluated by comparing the proposed optimized plan with the original plan. Figure 1 shows a high-level overview of this automated planning framework.
A. OAR 3D DOSE DISTRIBUTION PREDICTION
The 3D dose distributions of OARs are predicted based on an in-house geometry-dosimetry correlation model, which takes all the voxels within an OAR as research subjects, and their doses as output, and the individualized geometrical features including its location and volumetric information as inputs ( Table 1 ). This model is trained using a feed forward backpropagation neural network [29] , with 1 input layer (9 nodes), 3 hidden layers (9 nodes), and 1 output layer (1 node).
25 clinically treated GYN cancer IMRT plans were collected and retrospectively studied, with prescription dose of 45 Gy to the PTV, and treated with 7 beams (i.e., 150 o , 100 o , 50 o , 0 o , 310 o , 260 o , 210 o ). All these IMRT plans were originally designed from the commercial Eclipse TPS (Varian Medical Systems, Palo Alto, CA) with generation via DV-based optimization. Guidelines for optimization goals and constraints and also the final plan quality check was the International of Radiotherapy Technology Effectiveness in Cervical Cancer (INTERTECC) protocol. The set of OARs includes the rectum and bladder, PTV is the only target. 80% cases were randomly selected as training set and the rest as testing set for each iteration of training, with a total of 4 iterations. 10 individual cases were selected from 4 testing sets to evaluate, whose prediction accuracy was measured as the relative root mean square error/ prescription dose averaged over the regions of interest (ROIs) voxels and tested cases, as illustrated in Table 2 . The average dose prediction error for rectum and bladder are 2.69% and 2.98%, respectively. 
B. PREDICTION GUIDED OPTIMIZATION MODEL
Considering there are uncertainties with dose prediction, a proper prediction guided optimization has to be able to not only orient the optimized dose to predicted, but also fulfill its inherent purpose, which is sparing the OAR to the utmost. Here, we reformulated a traditional quadratic penalty based FMO model by replacing OAR's dose reference with predictions and employing an equivalent uniform dose sparing. Dose controls to PTV and its surrounding volume are simultaneously considered. Hence, a new prediction-guided FMO is established, as formulated in Eq. (1), as shown at the top of the next page. Its objective consists four parts: the first two parts orient the OAR doses to prediction and lower them as much as possible, the third part prescribes the PTV and the last part provides PTV-surrounding normal tissue (NT) with a reasonable fall-off dose. N OARs and N PTVs are numbers of OARs and targets, respectively. NT is the 1 cm shell region isotropically expanded from the union of PTV, notating (PTV+1 cm)−PTV. d(x)=W·x calculates the dose distribution vector, where W is the dose deposition matrix and x is the fluence map. W is precalculated using quadrant infinite beam dose engine (QIB) implanted in computational environment for radiotherapy research platform (CERR) [30] by applying the incident beam configurations borrowed from the original. The fluence plane is discretized into 5×5 mm 2 bixels and all the voxels are sized of 3 × 3 × 3 mm 3 .
As FMO does, this optimization model takes fluence map x as variable, with respect to objective F and practical dose constraints C. F is summed over 4 subunit weighted objectives. The sub-objective f optimizes the OAR dose distribution to be close to the predicted one d Pred. , the sub-objective gEUD is
general equivalent uniform dose function that provides incentive to further reduce the OAR doses as much as possible, and g is a commonly used uniform dose function that optimizes all target voxels to receive prescription, h optimizes the doses of partial NT to meet a certain fall-off pattern, formulized similarly as f but with a fall-off dose distribution d NT as the reference, d NT is calculated though a dose fall-off function [31] . C are the dose and dose-volume based constraint functions. w is the weighting coefficient for objectives.
1) USING DOSE PREDICTION SEQUENCING AS REFERENCE
Rather than zero dose or tolerance dose [32] , proposed optimization method referenced voxel-based dose distribution prediction as the ideal dosimetric goal for OARs. There are two reasons: (1) predicted dose distribution has the information of ideal trade-offs for an individual, which is instructive to guide a patient-specific optimization.
(2) 3D dose as goal makes it easier to fine-tune the doses to control dosimetric performance over the dose grid. The applied prediction based objective function for OAR is formulated in Eq. (2), where v is the cumulative volume vector. This function aims to minimize the discrepancies between the current dose and its position-matched predicted one. With this objective, the dose distribution could be precisely sculpted.
2) INTEGRATING gEUD FOR CONDUCTING PREDICTION VARIATIONS
A prediction based objective can guarantee a predictionlike plan. However, a loose or tight dose prediction might theoretically lead to a suboptimal or infeasible plan. For a simple but straightforward study, we constructed several predicted dose goals with different accuracy and applied them for sole prediction guide optimization, objective function as equation (2). The original dose distribution (Ori.), was used as 100% precise predicted dose, and its two-side relaxations, as loosened and tightened predicted dose, by giving every voxel dose a same relaxation rate (RR), RR>100% means the dose distribution was loosened. Beyond that, we enlarged the RR to two specific situations with references utilizing zero dose and empirical averaged dose (over 10 test cases), respectively. Set of the parameters unchanged for a fair comparison. Figure 2 .1 shows the plan-quality transitioning tendency of different ''prediction'' guided plans (RR Ori. plan) along the elastic degree. It can be observed that: (1) the plan quality got inferior as dose distribution guideline got looser;
(2) as the dose distribution goal got tighter, included OARs all became better, however, the PTV dose coverage and homogeneity became worse, particularly when the rate was >5%. As a conclusion, the results reveal that the dosimetric prediction is important to generate a high-quality plan, however, the predicted error do cause plan variations.
To deal with the limitation of the predicted dose distribution, we integrated a gEUD objective into the optimization model. The gEUD, as formulated in Eq. (3), has a strictly positive gradient with respect to dose, suggesting that it always tries to reduce the dose for all OAR voxels, therefore leaves no room for improvement and pushes the optimized plan towards optimal. Besides, gEUD sparing and predicted dose distribution could complement each other, the former expends the prediction's ability as a guideline, whereas the latter has more controls over details of dose distribution.
where α is a parameter that describes the dose-volume effect. In this study, α is set to 2 for rectum and bladder in order to reduce the high dose mostly but also mean dose of all the voxels [33] .
C. EVALUATION
The evaluations of proposed optimization are based on the aforementioned 10 dosimetry-prediction model tested GYN IMRT cases. For each case, it plan is re-optimized using this proposed method (Proposed plan).
Firstly, to demonstrate the respective effectiveness of prediction and gEUD on planning optimization, more specific the plan quality influence, we took one case as an example and implemented our proposed optimization techniques sequentially with first step to generate plan only guided by the prediction (sole prediction guided, output plan is noted as Pred. plan). Second step is additionally performing the gEUD term on the basis of step1, and obtain the Proposed plan. The Pred. plan was first compared with original plan (Ori.) to evaluate the prediction's function as optimization guideline, then compared with Proposed plan to describe the influence of gEUD term on assisting a prediction guided plan. Moreover, to further prove that the cooperation of prediction and gEUD is necessary, we also implemented a sole gEUD based plan (taking only the proposed gEUD part, and noted as gEUD plan), and compared it with Pred. plan and Proposed plan.
Secondly, to validate the performance of proposed method on dealing with prediction error, and as a follower to Figure 2. (1), we used the original OAR dose and its two-sided relaxations as the ''predictions'' to guide replace the predicted reference in the proposed optimization, same methodology was implemented to generate proposed optimized plans. The Proposed plan guided by 100% accurate prediction was compared with the ones by the actual prediction, the loosened and tightened ''predictions''.
Finally, to specifically evaluate the performance of proposed optimization, we compare the Proposed plan with Ori. on plan quality in terms of dose distribution, DVH and dosimetric endpoints. A paired t test was also performed onto endpoints for all evaluated IMRT cases to synoptically investigate the plan quality differences.
A limited Broyden-Fletcher-Goldfarb-Shanno (L-BFGS)sequential quadratic programming (SQP) algorithm [34] is employed to solve this optimization problem with maximum iteration set to 120 for an approximate convergence. By this algorithm, a nonlinear inequality constrained optimization could be simplified to be quadratic programming problem, with an L-BFGS approximation to define the hessian matrix for providing fast and super-linear optimization convergence. The dose and DVH constraints we use both involve a smooth approximation to provide continuous gradients to the optimizer, by using normalized smooth logistic functions to approximate the original function [35] , [36] .
The optimization problems were solved using Matlab 2016b on a computer with a Quad-core 3.4 GHz Intel processor and 8 GB of memory. For the trade-offs between ROIs are quantized as prediction, the choice of the weight factor set for all the objectives become less sensitive. w for f in Eq. (1) are all set to 1, 6e-04 for gEUD, 0.5 for g, and 0.2 for h, respectively, and they are chosen by several trials. The fall-off dose for NT is calculated based on reference [30] and experience. C are set based on experience and clinical protocol: D 99% ≥43.2 Gy, D 97% ≥44.1 Gy, V 99% ≥94%, D 1% ≤49 Gy, D 10% ≤48 Gy, D max ≤51 Gy for PTV, D max ≤ 50 Gy for (PTV+1 cm)−PTV and D max ≤43.5 Gy for BODY-(PTV+1 cm).
III. RESULTS

A. THE EFFECT OF PREDICTION AND gEUD ON OPTIMIZED PLAN
Taking GYN case 6 as an example, the DVH differences from Ori. to Pred. plan and Proposed plan are shown in Figure 3 . (A), it can be observed that both rectum and bladder are improved by the prediction, the V 30 , V 45 of rectum got decreased by 8.93%, 18.86%, respectively, and bladder got decreased by 19.82%, 14.25%, respectively. Pred. plan is then further improved by gEUD, V 30 , V 45 of rectum got much decreased by 4.36%, 7.78%, and bladder by 6.46%, 7.33%, respectively. However, PTVs of 3 plans are comparable. For 10 evaluated GYN cases, the average V 30 , V 45 of rectum were first decreased by (4.97±5.75) %, (9.87±7.50) %, and further decreased by (3.44±2.23) %, (5.62±2.00) %, respectively. V 30 , V 45 of bladder were first decreased by (8.36±3.87) %, (9.23±3.80) %, then further decreased by (6.11±1.84) %, (5.00±2.43) %, respectively. Furthermore, Figure 3. (B) illustrates the comparisons among Pred. plan, gEUD plan and the Proposed plan, which shows that there're trade-offs between Pred. plan and gEUD plan, rectum of the former is much better while its bladder is worse than the latter, but Proposed plan performs the finest and rather superior than the other 2, reveal that the cooperation of prediction and gEUD on optimization is necessary and effective.
The results show that the prediction and gEUD both contribute greatly to the planning optimization.
B. PERFORMANCE OF THIS METHOD ON HANDLEING PREDICTED ERROR
The DVH comparisons for the Proposed plan (Ori.) with Proposed plan (Pred.), as well as the ones guided by the loosened and tightened original dose on GYN case 6 are shown in Figure 4 . (A), (B) and (C), respectively. It is observed that: (1) the Proposed plans guided by prediction and the original dose are rather similar, with no distinct differences;
(2) With a loosening rate less than 20%, Proposed loose 'prediction' guided plans are all comparable to the one by original dose, they are quite similar in spite of degree changes of the prediction error. But when it >=20%, distinct plan quality-loss starts to occur in the optimized plan; (3) there's a balance kept by proposed method when prediction goal got tightened, the high-dose (over 36 Gy) volumes of both rectum and bladder decrease while their low-dose volumes increase as the tightening precedes, the dose coverage and homogeneity of PTV are worse, significantly after the tightening rate reaches 5%.
The results indicate that proposed optimization method works effectively on handling the prediction error.
C. QUALITY COMPARISON BETWEEN PROPOSED PLAN AND ORIGINAL PLAN
For all 10 GYN cases, their DVHs comparisons of PTV, rectum and bladder between Proposed plan and Ori. are illustrated in Figure 5 . Results show plan improvement accomplished by proposed method, rectum and bladder are both distinctly improved, hot spots volume of PTV decrease in most cases. Taking case 3 as an example, their dose distribution comparison is illustrated in Figure 6 , it shows that all tagged isodose lines inside both rectum and bladder are improved by proposed method.
More specifically, the average dosimetric endpoints comparisons of all 10 cases were recorded and applied for statistical, as illustrated in Table 3 . It can be observed that optimized plan comparing with original plan, not only PTV is improved, but also more dose sparing for OARs, with better dose provides a feasible and fast solution, implemented only by one optimization, which take 100-108 iterations to convergence, lasts 40-50 minutes, and yet requires no additional manual intervention once the parameters are initially set.
The results show that proposed method could afford a better plan quality while significantly reduce the current trialand-error patterned planning workload.
IV. DISCUSSION AND CONCLUSION
On basis of the 3D dose distribution we predicted and with the idea of making the most of prediction while aiming for an optimal plan, we proposed a predicted dose distribution and gEUD based automatic planning optimization method, which takes predicted dose distribution as initial dosimetric goal to push the optimized plan to be at least good as the predicted one and also incorporates extra equivalent uniform dose sparing for OARs to further improve plan towards optimal. 10 clinical GYN IMRT cases were used to get evaluated about this method. The results showed that the proposed optimization method ensured the output plan quality for IMRT and significantly reduced the current trial-and-error patterned planning workload. In addition, the comparisons between proposed plan and sole prediction guided plan as well as the gEUD based optimized plan showed that the integration of prediction and gEUD is beneficial and rather necessary.
The proposed method is based on a 3-dimensional dose distribution prediction model to afford a well-selected starting point. Hence, a reasonable prediction accuracy is assumed, e.g. within ±20%. When dealt with loose predictions (>100% precise prediction), the proposed gEUD term would stimulate and consequently further spare the OAR dose to its extreme. If predicted goal is tight (<100% precise prediction), the gEUD term would be negligible comparing to the prediction achieving part, then it makes the optimization problem back to the trade-off selection and hence the optimization could be forced too much on sacrificing PTV, defined hard constraints for PTV might not hold out, and the optimization would fail. These situations would be exacerbated when reasonable prediction accuracy is beyond. To address this problem, the predicted goal has to be accurate or properly loosened, which can be implemented by establishing an auto prediction fine-tuning strategy in optimization based on clinical preference. For instance, if PTV constraints aren't met, the predicted goals or their weight of an OAR or certain OAR volume should be loosened repeatedly by following a reverse clinical priority order, to satisfy the PTV constraints. Then, potential loose goals should be tightened from high-priority to low-priority until any constraint violations, to strive for an optimal solution.
As another realization to the KBTP, our proposed method should be further and wildly evaluated, especially have it compared to clinical commercial ones, for example the RapidPlan. This would be conducted after obtaining access to this module. In our prediction model, input features were handcrafted by experience, the information that effects the final deposited dose might not be fully completed. To reinforce the performance of the prediction model, we could include a convolutional neural network (CNN) to allow the features to be fully learned and connected on their own. It should also be notice that, the fluence plane was discretized into 5 × 5 mm 2 in this study, but the thickness of MLC for some accelerator and the area of minimum segment are beyond that, for situations like these, the final delivered dose may get affected. Moreover, experimental data about this method might not be quite representative, considering the complicated clinical situations, we tested other GYN IMRT cases with a prescription of 50.4 Gy for the evaluation of this method, the results were similarly optimistic. However, further application on other tumor sites should evaluated in the future.
In conclusion, we have successfully developed a novel automatic optimization method based on predicted dose distribution and gEUD sparing. This method is able to make full use of 3D dose prediction, ensure the plan quality for IMRT and significantly reduce current trial-and-error patterned planning workload. It can provide a novel way and evaluation basis for more sophisticated and robust prediction guided automatic treatment planning.
